美股市場個股詳情

MRK 默沙東

添加自選
  • 92.250
  • +1.670+1.84%
收盤價 02/28 16:00 (美東)
  • 92.150
  • -0.100-0.11%
盤後 19:55 (美東)
2330.27億總市值13.69市盈率TTM

關於默沙東公司

默沙東公司是一家醫療保健公司,通過其處方藥、疫苗、生物療法、動物健康和消費者護理產品提供健康解決方案。它通過以下部門運作:製藥,動物健康和其他。製藥部門包括人類健康藥品和疫苗產品。動物保健部門發現、開發、製造和銷售動物保健產品,如藥品和疫苗產品,用於預防、治療和控制牲畜和伴侶動物物種的疾病。其他部分包括醫療保健服務的非報告部分的銷售。

公司介紹

公司代碼MRK
公司名稱默沙東
上市日期1946/05/15
成立日期1891
CEOMr. Robert M. Davis
所屬市場紐交所
員工數量75000
年結日12-31
公司地址126 East Lincoln Avenue
城市Rahway
省份新澤西
國家美國
郵編07065
電話1-908-740-4000

董事高管

  • 姓名
  • 職務
  • 年薪
  • Robert M. Davis
  • Chairman of the Board, President and Chief Executive Officer
  • 2027.33萬
  • David Michael Williams
  • Executive Vice President and Chief Information and Digital Officer
  • --
  • Michael A Klobuchar
  • Executive Vice President and Chief Strategy Officer
  • --
  • Betty D. Larson
  • Executive Vice President and Chief Human Resources Officer
  • --
  • Caroline A. Litchfield
  • Executive Vice President and Chief Financial Officer
  • 830.04萬
  • Chirfi Guindo
  • Senior Vice President, Human Health and Chief Marketing Officer
  • --
  • Cristal N. Downing
  • Executive Vice President and Chief Communications and Public Affairs Officer
  • --
  • Dalton E. Smart, III
  • Senior Vice President, Finance, Global Controller and Principal Accounting Officer
  • --
  • Sanat Chattopadhyay
  • Executive Vice President and President, Merck Manufacturing
  • 624.04萬
  • Dean Y. Li
  • Executive Vice President and President, Merck Research Laboratories
  • 977.94萬
  • Jennifer Zachary
  • Executive Vice President and General Counsel
  • --
  • Richard R. DeLuca, Jr
  • Executive Vice President and President, Merck Animal Health
  • 619.79萬
  • Joseph Romanelli
  • Senior Vice President and President, MSD, International Human Health
  • --
  • Jannie Oosthuizen
  • Senior Vice President and President, Merck U.S. Human Health
  • --
  • Surendralal L. Karsanbhai
  • Director
  • --
  • Dr. Stephen L. Mayo, PhD
  • Independent Director
  • 35.00萬
  • Douglas M. Baker, Jr
  • Independent Director
  • 34.76萬
  • Patricia F. Russo
  • Independent Director
  • 36.00萬
  • Thomas Henry Glocer
  • Lead Independent Director
  • 43.01萬
  • Kathy J. Warden
  • Independent Director
  • 35.00萬
  • Dr. Risa J. Lavizzo-Mourey,M.D.
  • Independent Director
  • 36.50萬
  • Dr. Christine E. Seidman, M.D.
  • Independent Director
  • 35.00萬
  • Dr. Paul B. Rothman, M.D.
  • Independent Director
  • 38.00萬
  • Mary Ellen Coe
  • Independent Director
  • 34.24萬
  • Inge G. Thulin
  • Independent Director
  • 34.00萬
  • Pamela J. Craig
  • Independent Director
  • 40.00萬
市場投資機會
成長股 成長股

成长股策略挑选具有卓越增长表现的企业。聚焦流通市值≥5亿美元、净利润增长率年报≥15%、毛利率≥50%、净资产收益率年报≥15%且ROE同比增长率>50%的股票,旨在寻找财务状况强劲且成长性极高的公司。 成长股策略挑选具有卓越增长表现的企业。聚焦流通市值≥5亿美元、净利润增长率年报≥15%、毛利率≥50%、净资产收益率年报≥15%且ROE同比增长率>50%的股票,旨在寻找财务状况强劲且成长性极高的公司。